The NCCN’s updated guidelines for the treatment of breast cancer include updates on sentinel lymph node biopsy, ovarian function suppression, and the use of prognostic tools.
The National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines in Oncology to include ...
PharmaEssentia Announces Updated NCCN Clinical Practice Guidelines Include ropeginterferon alfa-2b-njft (BESREMi®) for ...
In a significant shift for the treatment landscape of essential thrombocythemia (ET), the US National Comprehensive Cancer Network (NCCN) has designated ropeginterferon alfa-2b-njft (Besremi) as a ...
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles ...
US biotech Gilead Sciences today announced that its Trodelvy (sacituzumab govitecan-hziy) has now been added to the National ...
Epic Systems and the National Comprehensive Cancer Network are working in collaboration to integrate the NCCN Chemotherapy Order Templates into Epic’s Beacon Oncology Information System. The new ...
The NCCN summit emphasized the need for improved communication between oncology and primary care to enhance patient outcomes. The OCM and EOM have advanced oncology care coordination but lack ...
2d
Exact Imaging Reports Strong Momentum Driven by Commercial Execution and Clinical Validation in 2025
Exact Imaging, a global leader in high-resolution micro-ultrasound systems for prostate cancer, today reported strong ...
Making clinical trials easier to find for clinicians and making protocols for entering clinical trials more lenient can help to improve access to clinical trials on a national and local level, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results